Orion Pharma
Orion Pharma is a Private limited company (Ltd.) registered in Belgium under 0821527741, and its current status with Crossroads Bank for Enterprises (KBO/BCE) is active. The company was incorporated on 17 December 2009 and lists its registered address as Belgium. 1 shareholder is on record for Orion Pharma, and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from Crossroads Bank for Enterprises (KBO/BCE) and was last updated on 19 October 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
1
One shareholder is currently on record for Orion Pharma, reflecting the registre des actions nominatives (register of registered shares) kept by the company under the Code des sociétés et des associations rather than a public filing.
The largest of these is Orion Corporation, holding 100% — a majority holding.
Because the shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| Orion Corporation | 100% | Crossroads Bank for Enterprises (KBO/BCE) |
Officers
5
The Director of Orion Pharma currently on record is SATU AHOMAKI; five officers are currently on record for Orion Pharma, filed with Crossroads Bank for Enterprises (KBO/BCE).
Management authority at Orion Pharma sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Group Structure
Orion Pharma sits 1 level below its ultimate parent, Orion Oyj, registered in Finland. The full chain up to Orion Oyj is derived by walking shareholder filings across jurisdictions; no link in it is independently corroborated by Orion Pharma's own shareholder record.
Orion Oyj
Finland
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns Orion Pharma?
One shareholder is currently on record for Orion Pharma, reflecting the registre des actions nominatives (register of registered shares) kept by the company under the Code des sociétés et des associations rather than a public filing. The largest of these is Orion Corporation, holding 100% — a majority holding. Because the shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is Orion Pharma's UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for Orion Pharma is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does Orion Pharma have on record?
1 shareholder is shown on record for Orion Pharma.
What is Orion Pharma's company registration number?
Orion Pharma's registration number is 0821527741, filed with Crossroads Bank for Enterprises (KBO/BCE) in Belgium. Its current status on the register is active.
Is Orion Pharma still an active company?
Orion Pharma's status on Crossroads Bank for Enterprises (KBO/BCE) is listed as active.
When was Orion Pharma incorporated?
Orion Pharma was incorporated on 17 December 2009, according to Crossroads Bank for Enterprises (KBO/BCE).
What is Orion Pharma's registered address?
The registered address on file for Orion Pharma is Belgium.
What legal structure is Orion Pharma registered as?
Orion Pharma is registered as a Private limited company (Ltd.) in Belgium.
Who are the officers/directors of Orion Pharma?
The Director of Orion Pharma currently on record is SATU AHOMAKI; five officers are currently on record for Orion Pharma, filed with Crossroads Bank for Enterprises (KBO/BCE). Management authority at Orion Pharma sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Does Orion Pharma have a parent company or subsidiaries?
Orion Pharma sits 1 level below its ultimate parent, Orion Oyj, registered in Finland.
Can Zavia monitor changes to Orion Pharma's ownership over time?
This profile reflects a point-in-time snapshot from Crossroads Bank for Enterprises (KBO/BCE). Zavia's monitoring API can track changes to Orion Pharma's registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access Orion Pharma's data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including Belgium, so records like Orion Pharma's registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from Crossroads Bank for Enterprises (KBO/BCE) and was last synced on 19 October 2026.